ライフサイエンスコーパス: simian immunodeficiency virus

1 uent mucosal challenge with a chimeric human/simian immunodeficiency virus.

2 induction by HIV, murine leukemia virus, and simian immunodeficiency virus.

3 , some of which may be linked to response to simian immunodeficiency virus.

4 d with non-MTB bacterial pathogens, nor with simian immunodeficiency virus alone.

5 NK cell activity in cells infected with HIV, simian immunodeficiency virus, and other persistent viru

6 s that were molecularly engineered with anti-simian immunodeficiency virus (anti-SIV) activity into r

7 nated monkeys to clear a subsequent virulent simian immunodeficiency virus challenge.

8 We used Mycobacterium tuberculosis/simian immunodeficiency virus-coinfected (M. tuberculosi

9 ctivation in the context of ART using TB and simian immunodeficiency virus-coinfected (TB/SIV-coinfec

10 y reactivation of latent infection following simian immunodeficiency virus coinfection.

11 ue lungs by DeltasigH was not reactivated by simian immunodeficiency virus, despite high viral levels

12 enhanced by substituting naturally occurring simian immunodeficiency virus Env residues at position 3

13 HIV-2 and some simian immunodeficiency viruses express viral protein X

14 ollowing the cross-species transmission of a simian immunodeficiency virus from chimpanzees (SIVcpz)

15 the result of cross-species transmission of simian immunodeficiency virus from chimpanzees (SIVcpz).

16 evant rhesus macaque model of infection with simian immunodeficiency virus from sooty mangabey (SIVsm

17 via distinct zoonotic transmission events of simian immunodeficiency viruses from chimpanzees and soo

18 en widely accepted to be the consequences of simian immunodeficiency viruses from wild chimpanzees (S

19 To address this question, we have analyzed simian immunodeficiency virus Gag-specific CD8(+) T cell

20 by electroporation (DNA/EP), all expressing Simian immunodeficiency virus group specific antigen/tra

21 Chronic human immunodeficiency virus and simian immunodeficiency virus (HIV and SIV) infections a

22 The cytoplasmic tails of human and simian immunodeficiency virus (HIV and SIV, respectively

23 d rhesus macaques infected with the human or simian immunodeficiency virus (HIV or SIV), respectively

24 thway in human immunodeficiency virus type 1/simian immunodeficiency virus (HIV-1/SIV) infection rema

25 or site of inflammation during chronic human/simian immunodeficiency virus (HIV/SIV) infection.

26 virus (CMV) and human immunodeficiency/virus simian immunodeficiency virus (HIV/SIV) infections.

27 ence of a distinct subpopulation of human or simian immunodeficiency virus (HIV/SIV) sequences within

28 Human and simian immunodeficiency viruses (HIV and SIV) exploit fo

29 ally inhibit lentiviruses, such as human and simian immunodeficiency viruses (HIV and SIV), irrespect

30 ant for controlling replication of human and simian immunodeficiency viruses (HIV and SIV).

31 Human and simian immunodeficiency viruses (HIV/SIVs) use CD4 as th

32 emained at protective levels despite chronic simian immunodeficiency virus/HIV-induced immunosuppress

33 Nef alleles from divergent clades of HIV and simian immunodeficiency virus, including from primary pa

34 However, simian immunodeficiency virus-induced reactivation of la

35 PH, in mice with hypoxia-induced PH, and in Simian immunodeficiency virus-infected macaques, in whic

36 Notably, evaluation of simian immunodeficiency virus-infected nonhuman primates

37 V) infection and colocalize in the aortas of simian immunodeficiency virus-infected nonhuman primates

38 emia in antiretroviral therapy (ART)-treated simian immunodeficiency virus-infected rhesus macaques (

39 We therefore used antifibrotic therapy in simian immunodeficiency virus-infected rhesus macaques t

40 the gut is well-maintained in nonpathogenic simian immunodeficiency virus infection as well as HIV-1

41 ontaining protein 1 (SAMHD1) restricts human/simian immunodeficiency virus infection in certain cell

42 dge gained from studies in non-human primate simian immunodeficiency virus infection models.

43 tection from human immunodeficiency virus or simian immunodeficiency virus infection remain incomplet

44 Despite acute simian immunodeficiency virus infection, all animals rem

45 Here we show that in simian immunodeficiency virus infection, these cells are

46 agrees well with the experimental data from simian immunodeficiency virus infections in morphine-add

47 tudying adaptation to host SAMHD1 in natural simian immunodeficiency virus infections of African Gree

48 s among uninfected animals exposed to HIV or simian immunodeficiency virus, irrespective of route of

49 odeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus isolate it has been tested

50 ng limiting-dose inoculations with a diverse simian immunodeficiency virus isolate stock may increase

51 smission in nonhuman primates with a diverse simian immunodeficiency virus isolate stock may increase

52 e of the Vif substrate receptor complex from simian immunodeficiency virus isolated from red-capped m

53 of neutralization-resistant HIV-1, HIV-2 and simian immunodeficiency virus isolates, including a comp

54 eta(+) T cells to control of live-attenuated simian immunodeficiency virus (LASIV) replication during

55 ctious molecular clones from two widely used simian immunodeficiency virus lineages (SIVmac251 and SI

56 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus mac239 (SIV(mac239)) repli

57 viremia after infection with the pathogenic simian immunodeficiency virus mac239 (SIVmac239) clone.

58 and our current understanding comes from the simian immunodeficiency virus macaque model.

59 The Nef proteins of human and simian immunodeficiency viruses manipulate infected CD4(

60 udy, we demonstrated that HIV-1 NL4-3 with a simian immunodeficiency virus mne (SIVmne) vif gene subs

61 Here, we used the rhesus macaque simian immunodeficiency virus model with and without ant

62 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus of macaques (SIV(MAC) and

63 l reservoir during infections with HIV-1 and simian immunodeficiency virus of macaques (SIVmac).

64 degradation and inhibited wild-type SIVmac (simian immunodeficiency virus of macaques) infection of

65 iral protein X (Vpx) proteins from the major simian immunodeficiency virus of rhesus macaque, sooty m

66 cytomegalovirus (RhCMV) strain 68-1-vectored simian immunodeficiency virus (RhCMV/SIV) vaccines are a

67 the differences between the Env proteins of simian immunodeficiency virus/simian HIV (SIV/SHIV) stoc

68 ugh nonhuman primate studies have shown that simian immunodeficiency virus/simian-human immunodeficie

69 exposed them intrarectally to a dose of the simian immunodeficiency virus SIV(mac251) that transmits

70 However, with the exception of simian immunodeficiency virus (SIV) (family Retroviridae

71 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) acquisition in human

72 imian-human immunodeficiency virus (SHIV) or simian immunodeficiency virus (SIV) acquisition in three

73 Macrophages (M ) are infected by HIV/simian immunodeficiency virus (SIV) and are likely to ca

74 ine-induced antibodies to capture infectious simian immunodeficiency virus (SIV) and explored the rel

75 We found here that an ALVAC-simian immunodeficiency virus (SIV) and gp120 alum (ALVA

76 cent structures of lentiviral intasomes from simian immunodeficiency virus (SIV) and HIV have clarifi

77 Simian immunodeficiency virus (SIV) and human immunodefi

78 A hallmark of pathogenic simian immunodeficiency virus (SIV) and human immunodefi

79 ata from macaques infected with a mixture of simian immunodeficiency virus (SIV) and simian-human imm

80 n monkeys (AGMs) are naturally infected with simian immunodeficiency virus (SIV) at high prevalence l

81 Natural hosts of simian immunodeficiency virus (SIV) avoid AIDS despite l

82 infection and, to a lesser extent, HIV-2 and simian immunodeficiency virus (SIV) because of their vir

83 ations of male rhesus macaques infected with simian immunodeficiency virus (SIV) but not in uninfecte

84 nodes from pigtailed macaques infected with simian immunodeficiency virus (SIV) carrying HIV-1 rever

85 e that showed significant protection against simian immunodeficiency virus (SIV) challenge and sugges

86 work and have been tested extensively in the simian immunodeficiency virus (SIV) challenge macaque mo

87 We compared the relative efficacies against simian immunodeficiency virus (SIV) challenge of three v

88 e route on protection against a heterologous simian immunodeficiency virus (SIV) challenge.

89 or remain unvaccinated and then undergo oral simian immunodeficiency virus (SIV) challenges 3 weeks l

90 confer partial protection against stringent simian immunodeficiency virus (SIV) challenges in rhesus

91 a late boost and three additional series of simian immunodeficiency virus (SIV) challenges in seven

92 caques infected with an attenuated strain of simian immunodeficiency virus (SIV) containing a stop co

93 cytes (CD8TL) are associated with control of simian immunodeficiency virus (SIV) despite extensive ne

94 se macaques consistently displayed low-level simian immunodeficiency virus (SIV) diversity, which was

95 ls (DCs) and B cells, as an adjuvant for our simian immunodeficiency virus (SIV) DNA vaccine in rhesu

96 The Nef accessory protein of simian immunodeficiency virus (SIV) engages the clathrin

97 y or hydrophobic residues typically found in simian immunodeficiency virus (SIV) Env to improve rhesu

98 mmunization, or the capacity to neutralize a simian immunodeficiency virus (SIV) Env-expressing pseud

99 human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus (SIV) envelope spike (Env)

100 tructurally conserved parts of the HIV-1 and simian immunodeficiency virus (SIV) Envs.

101 ural-host sooty mangabeys (SM) infected with simian immunodeficiency virus (SIV) exhibit high viral l

102 nt study, we found that protection following simian immunodeficiency virus (SIV) exposure correlated

103 TANCE Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) express a small prot

104 lymorphism limits and complicates the use of simian immunodeficiency virus (SIV) for evaluation of hu

105 We deep sequenced simian immunodeficiency virus (SIV) from Mauritian cynom

106 s Indiana serotype (rVSIV) vector expressing simian immunodeficiency virus (SIV) gag and human immuno

107 MVA-B13R expressing simian immunodeficiency virus (SIV) Gag and Pol and HIV

108 When we introduced the simian immunodeficiency virus (SIV) gag gene into severa

109 L. monocytogenes elicited more potent simian immunodeficiency virus (SIV) Gag-specific CD8(+)

110 ycobacterium tuberculosis strains expressing simian immunodeficiency virus (SIV) genes safely induces

111 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) gp120 exterior envel

112 ons.IMPORTANCE Rhesus macaque infection with simian immunodeficiency virus (SIV) has served as an imp

113 ts of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) have been described

114 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) have evolved the Vif

115 African-origin, natural simian immunodeficiency virus (SIV) hosts do not typical

116 -1)-infected humans, African-origin, natural simian immunodeficiency virus (SIV) hosts, such as Afric

117 n immunodeficiency virus (HIV) in humans and simian immunodeficiency virus (SIV) in macaques (MAC) le

118 re we employed a barcoded synthetic swarm of simian immunodeficiency virus (SIV) in rhesus macaques t

119 erapy, showed consistent, durable control of simian immunodeficiency virus (SIV) in rhesus macaques.

120 on of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) in vivo is well esta

121 to which these populations were infected by simian immunodeficiency virus (SIV) in vivo, to determin

122 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) in vivo.

123 GI) tract of Asian macaques with progressive simian immunodeficiency virus (SIV) infection and humans

124 erable to human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection and thus a

125 s (RMs) vaccinated with Vif and Nef acquired simian immunodeficiency virus (SIV) infection at a lower

126 HIV/simian immunodeficiency virus (SIV) infection causes bre

127 The time to acquisition of simian immunodeficiency virus (SIV) infection following

128 ght contribute to the asymptomatic nature of simian immunodeficiency virus (SIV) infection in its nat

129 re changes in mucosal IL-10 signaling during simian immunodeficiency virus (SIV) infection in rhesus

130 n genes that show a response to experimental simian immunodeficiency virus (SIV) infection in vervet

131 AIDS caused by simian immunodeficiency virus (SIV) infection is associa

132 Using the simian immunodeficiency virus (SIV) infection model, we

133 re we studied progressive and nonprogressive simian immunodeficiency virus (SIV) infection models in

134 ly regarded as the main source of latent HIV/simian immunodeficiency virus (SIV) infection of adult h

135 age proliferation occurs in the brain during simian immunodeficiency virus (SIV) infection of adult m

136 Studies of natural, nonpathogenic simian immunodeficiency virus (SIV) infection of African

137 Alternative model systems based on simian immunodeficiency virus (SIV) infection of macaque

138 al reservoir is seeded rapidly after mucosal simian immunodeficiency virus (SIV) infection of rhesus

139 Here we show that simian immunodeficiency virus (SIV) infection of rhesus

140 Simian immunodeficiency virus (SIV) infection of rhesus

141 Comparison of the immunologic effects of simian immunodeficiency virus (SIV) infection on rhesus

142 Human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection results in

143 enesis of human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection, and block

144 BM-derived CD4(+) T cells, their fate during simian immunodeficiency virus (SIV) infection, and their

145 During acute simian immunodeficiency virus (SIV) infection, gut homin

146 n pathways involved in establishing systemic simian immunodeficiency virus (SIV) infection, we necrop

147 lls (ILCs) located in the colon secondary to simian immunodeficiency virus (SIV) infection.

148 mation and gut immune dysfunction during the simian immunodeficiency virus (SIV) infection.

149 on during human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection.

150 ospinal fluid of rhesus monkeys with chronic simian immunodeficiency virus (SIV) infection.

151 isposed to more pathogenic manifestations of simian immunodeficiency virus (SIV) infection.

152 ) T cells in rhesus macaques with or without Simian immunodeficiency virus (SIV) infection.

153 fitting the model to experimental data from simian immunodeficiency virus (SIV) infections in contro

154 Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections induce ro

155 Experimental simian immunodeficiency virus (SIV) infections of nonhum

156 Currently available simian immunodeficiency virus (SIV) infectious molecular

157 A subtype C isolate was similar, while a simian immunodeficiency virus (SIV) isolate showed signi

158 n activity prevalent among diverse HIV-1 and simian immunodeficiency virus (SIV) isolates.

159 or of apoptosis (IAP), AZD5582, reverses HIV/simian immunodeficiency virus (SIV) latency.

160 different human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) lentiviruses.

161 diated in part by CD4 T cells.IMPORTANCE The simian immunodeficiency virus (SIV) macaque model repres

162 ine oxidase (MAO) activity in the brain of a simian immunodeficiency virus (SIV) model of human immun

163 Findings obtained with the simian immunodeficiency virus (SIV) monkey model have pr

164 Studies in both humans and simian immunodeficiency virus (SIV) monkey models have i

165 Comparative analysis of HIV and simian immunodeficiency virus (SIV) Nef proteins in the

166 antagonism of monkey and great ape BST-2 by simian immunodeficiency virus (SIV) Nef.

167 Brain injury occurs within days in simian immunodeficiency virus (SIV) or human immunodefic

168 inical challenge studies have used cell-free simian immunodeficiency virus (SIV) or simian/human immu

169 8 Env can be incorporated into HIV-1 but not simian immunodeficiency virus (SIV) particles.

170 tissue (GALT) and have a key role in HIV and simian immunodeficiency virus (SIV) pathogenesis.

171 We found that simian immunodeficiency virus (SIV) protein-expressing r

172 Our approach was to deliver the entire simian immunodeficiency virus (SIV) proteome by serial v

173 ) lymphocyte-depleted macaques infected with simian immunodeficiency virus (SIV) provide an increasin

174 adenovirus type 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinants and boo

175 is of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) reflects a balance b

176 Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication in human

177 Chronic-phase HIV and simian immunodeficiency virus (SIV) replication is reduc

178 ions, human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication may cont

179 We developed a method to capture total-body simian immunodeficiency virus (SIV) replication using im

180 also predisposes rhesus macaques to control simian immunodeficiency virus (SIV) replication.

181 of early human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) replication.

182 vaccinated macaques dramatically suppressed simian immunodeficiency virus (SIV) replication: peak vi

183 The simian immunodeficiency virus (SIV) rhesus macaque model

184 sruption of the conserved motif GYxxO in the simian immunodeficiency virus (SIV) SIVmac239 envelope (

185 oding the well-characterized molecular clone simian immunodeficiency virus (SIV) SIVmac239, resulting

186 rarectal inoculation of rhesus macaques with simian immunodeficiency virus (SIV) SIVmac251 to examine

187 d in all primate lentiviruses, and its HIV-2/simian immunodeficiency virus (SIV) SIVsm paralogue Vpx,

188 Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) strains differ in th

189 The lentiviruses HIV and simian immunodeficiency virus (SIV) subvert intracellula

190 fected with Mycobacterium tuberculosis (Mtb)/simian immunodeficiency virus (SIV) suggests that cytopa

191 HIV and simian immunodeficiency virus (SIV) target CD4(+) T cell

192 abeys (SM) are well-studied natural hosts of simian immunodeficiency virus (SIV) that do not progress

193 e have successfully isolated a new strain of simian immunodeficiency virus (SIV) that is capable of e

194 olgus macaques (CMs) infected with wild-type Simian Immunodeficiency Virus (SIV) to those of CMs infe

195 g in rhesus macaques (Macaca mulatta) during simian immunodeficiency virus (SIV) transmission and acu

196 r entering a host cell, retroviruses such as simian immunodeficiency virus (SIV) uncoat, disassemblin

197 ted DNA/modified vaccinia virus Ankara (MVA) simian immunodeficiency virus (SIV) vaccine enhances pro

198 lls in GC B cell responses following various simian immunodeficiency virus (SIV) vaccine regimens in

199 alization sieve effect in a nonhuman primate simian immunodeficiency virus (SIV) vaccine trial (DNA p

200 Working with the macaque simian immunodeficiency virus (SIV) vaginal challenge mo

201 o evaluate antibody specificities induced by simian immunodeficiency virus (SIV) versus human immunod

202 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) viral infectivity fa

203 striction factor SAMHD1 using Vpx-containing simian immunodeficiency virus (SIV) virion-like particle

204 HIV-1 Vpr and HIV-2/simian immunodeficiency virus (SIV) Vpr and Vpx engage t

205 ned the G2/M arrest phenotypes of a panel of simian immunodeficiency virus (SIV) Vpr proteins.

206 20 of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) was investigated for

207 We report here, in simian immunodeficiency virus (SIV)+ rhesus macaques and

208 (HIV) emergence following human exposures to simian immunodeficiency virus (SIV), an understanding of

209 keys are susceptible to infection by HIV and simian immunodeficiency virus (SIV), and are considered

210 sory proteins of primate lentiviruses HIV-1, simian immunodeficiency virus (SIV), and BIV all form ub

211 viruses-feline immunodeficiency virus (FIV), simian immunodeficiency virus (SIV), and human immunodef

212 can green monkeys (AGM) are natural hosts of simian immunodeficiency virus (SIV), and infection in th

213 quely valuable for genetic investigations of simian immunodeficiency virus (SIV), for which it is the

214 mulated with a vaccine regimen that includes simian immunodeficiency virus (SIV), interleukin 2 (IL-2

215 sum A1 partially inhibited HIV-1, as well as simian immunodeficiency virus (SIV), murine leukemia vir

216 nhuman primates were coinfected with Mtb and simian immunodeficiency virus (SIV), recapitulating huma

217 ector to immunize monkeys with antigens from simian immunodeficiency virus (SIV), the macaque model f

218 orescence microscopy thoracic aortas from 16 simian immunodeficiency virus (SIV)- or simian-human imm

219 Studies of natural HIV-1 infection, simian immunodeficiency virus (SIV)- or simian-human imm

220 To this end, preclinical simian immunodeficiency virus (SIV)-based nonhuman prima

221 irus-specific cell-mediated immunity in both simian immunodeficiency virus (SIV)-infected and uninfec

222 ere validated in archival brain tissues from Simian Immunodeficiency Virus (SIV)-infected and uninfec

223 he rhesus macaque AIDS virus model, infusing simian immunodeficiency virus (SIV)-infected animals wit

224 ts were detectable, but increased 20-fold in simian immunodeficiency virus (SIV)-infected animals.

225 iciency virus (HIV)-infected individuals and simian immunodeficiency virus (SIV)-infected Asian macaq

226 ejuna, and livers of healthy and chronically simian immunodeficiency virus (SIV)-infected Asian macaq

227 In simian immunodeficiency virus (SIV)-infected Asian macaq

228 fected monocytes and macrophages to HIV- and simian immunodeficiency virus (SIV)-infected cells in vi

229 re loss of lean body mass and body weight in simian immunodeficiency virus (SIV)-infected juvenile rh

230 In simian immunodeficiency virus (SIV)-infected macaques, c

231 escape-associated compensatory mutations in simian immunodeficiency virus (SIV)-infected macaques.

232 ibe viral genomes persisting in ART-treated, simian immunodeficiency virus (SIV)-infected NHPs, simia

233 Using the simian immunodeficiency virus (SIV)-infected nonhuman pr

234 alleles likely affect viral diversity in the simian immunodeficiency virus (SIV)-infected pig-tailed

235 In a previous study, we found that in simian immunodeficiency virus (SIV)-infected rhesus maca

236 Antiretroviral-treated, chronically simian immunodeficiency virus (SIV)-infected rhesus maca

237 body-mediated CD8(+) lymphocyte depletion in simian immunodeficiency virus (SIV)-infected rhesus maca

238 s system (CNS) has not yet been reached, the simian immunodeficiency virus (SIV)-infected rhesus maca

239 A chronic ethanol feeding model in simian immunodeficiency virus (SIV)-infected rhesus maca

240 dictates the tempo of progression to AIDS in simian immunodeficiency virus (SIV)-infected rhesus maca

241 CV) in a naturally occurring lymphoma from a simian immunodeficiency virus (SIV)-infected rhesus maca

242 ), and it is capable of inducing diseases in simian immunodeficiency virus (SIV)-infected RM that are

243 Simian immunodeficiency virus (SIV)-infected sooty manga

244 cells or purified CD4(+) T cells from HIV or simian immunodeficiency virus (SIV)-infected subjects wi

245 Using simian immunodeficiency virus (SIV)-infected, long-term

246 duced probiotic Lactobacillus plantarum into Simian immunodeficiency virus (SIV)-inflamed intestinal

247 Using the simian immunodeficiency virus (SIV)-macaque model, we te

248 iva, and urine were evaluated in a cohort of simian immunodeficiency virus (SIV)-negative rhesus maca

249 Using a rhesus macaque model of simian immunodeficiency virus (SIV)-Plasmodium fragile c

250 Here, we show a population of simian immunodeficiency virus (SIV)-specific CD8 T cells

251 Human immunodeficiency virus (HIV)- and simian immunodeficiency virus (SIV)-specific CD8(+) T ce

252 Simian immunodeficiency virus (SIV)-specific CD8(+) T ce

253 esponses are necessary for immune control of simian immunodeficiency virus (SIV).

254 ants in inducing protective immunity against simian immunodeficiency virus (SIV).

255 monkeys (AGMs) are natural primate hosts of simian immunodeficiency virus (SIV).

256 ian-human immunodeficiency virus (SHIV), and simian immunodeficiency virus (SIV).

257 on by human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV).

258 noculation (days postinoculation [dpi]) with simian immunodeficiency virus (SIV).

259 ol of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV).

260 erons, and impaired response to infection by simian immunodeficiency virus (SIV).

261 ains including clinical isolates, as well as simian immunodeficiency virus (SIV).

262 used a nonhuman primate challenge model with simian immunodeficiency virus (SIV).

263 ocytes in ART-treated macaques infected with simian immunodeficiency virus (SIV).

264 t they are not natural hosts of HIV-1 or any simian immunodeficiency virus (SIV).

265 tion of Env defines pathogenic properties of simian immunodeficiency virus (SIV).

266 ) T cell activation, the main cell target of simian immunodeficiency virus (SIV)/HIV.

267 Chimeric simian immunodeficiency virus (SIV)/human immunodeficien

268 al, nasal, and vaginal vaccinations with DNA simian immunodeficiency virus (SIV)/interleukin-2 (IL-2)

269 Using the simian immunodeficiency virus (SIV)/rhesus monkey model

270 ssion, we performed a comprehensive study of simian immunodeficiency virus (SIV)/SHIV-infected infant

271 hanisms, we found that p21 impairs HIV-1 and simian immunodeficiency virus (SIV)mac reverse transcrip

272 n new rYF17D viruses expressing fragments of simian immunodeficiency virus (SIV)mac239 Gag, Nef, and

273 re targeted by primate lentiviruses (HIV and simian immunodeficiency virus [SIV]) are of intense inte

274 an immunodeficiency virus type 1 [HIV-1] and simian immunodeficiency virus [SIV]) if its activity is

275 f proteins of HIV-1 and African green monkey simian immunodeficiency virus (SIVagm) bind residue 128

276 an green monkeys (AGMs) are natural hosts of simian immunodeficiency virus (SIVAGM).

277 Ms; genus Chlorocebus) are a natural host of simian immunodeficiency virus (SIVAGM).

278 e detected in the blood of Gambian primates: simian immunodeficiency virus (SIVagm; in 42% of animals

279 etherin, is associated with the evolution of simian immunodeficiency virus (SIVcpz) into pandemic gro

280 man primates (NHPs) coinfected with a mutant simian immunodeficiency virus (SIVDeltaGY) that does not

281 Using the rhesus macaque simian immunodeficiency virus SIVmac251 model, we can co

282 While simian immunodeficiency viruses (SIVs) are generally non

283 Lentiviruses such as HIV-2 and some simian immunodeficiency viruses (SIVs) counteract the re

284 an immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency viruses (SIVs) evolved through t

285 lentiviruses reveals that several species of simian immunodeficiency viruses (SIVs) have lost the gly

286 ependent cross-species transmission event of simian immunodeficiency viruses (SIVs) infecting African

287 protein encoded by HIV-1 as well as by some simian immunodeficiency viruses (SIVs) infecting wild ch

288 singly, however, the Vpu proteins encoded by simian immunodeficiency viruses (SIVs) of African guenon

289 Simian immunodeficiency viruses (SIVs) use their Nef pro

290 er lentiviruses, including HIV-2 and related simian immunodeficiency viruses (SIVs), SAMHD1 restricti

291 es, despite extensive sequencing of HIVs and simian immunodeficiency viruses (SIVs).

292 Simian immunodeficiency virus SIVsab infection is comple

293 ng a function of a cellular chaperone, since simian immunodeficiency virus T antigen was previously s

294 ed and published a description of a barcoded simian immunodeficiency virus that has a short random se

295 from cross-species transmission of SIVcpz, a simian immunodeficiency virus that naturally infects chi

296 wing treatment, animals were coinfected with simian immunodeficiency virus to assess reactivation of

297 Studies of vaginal transmission of simian immunodeficiency virus to nonhuman primates (NHPs

298 h Nef is the viral gene product used by most simian immunodeficiency viruses to overcome restriction

299 We found that some simian immunodeficiency viruses use arrays of glutamine

300 Most simian immunodeficiency viruses use their Nef protein to